FDA Inspection 1263751 — Libby Laboratories, Inc.

Libby Laboratories, Inc. — FEI 2912388

The FDA completed an inspection of Libby Laboratories, Inc. on March 14, 2025 in Berkeley, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Berkeley, CA (United States)

Citations

IDCFRDescription
180121 CFR 211.84(a)Components withheld from use pending release
188521 CFR 211.165(b)Microbiological testing